World News

PAXG Significantly Improves EFS Compared with mFOLFIRINOX in Patients with Resectable...

Ogkologos - 9 Φεβρουαρίου, 2026

EMA Recommends Extension of Therapeutic Indications for Retifanlimab

Ogkologos - 6 Φεβρουαρίου, 2026

Adding Palbociclib to Maintenance Anti-HER2 and Endocrine Therapies Improves PFS Over...

Ogkologos - 5 Φεβρουαρίου, 2026

FDA Grants Traditional Approval to Pirtobrutinib for Chronic Lymphocytic Leukaemia and...

Ogkologos - 4 Φεβρουαρίου, 2026

ESMO Launches Its Roadmap 2030 to Support Oncology Professionals and Foster...

Ogkologos - 4 Φεβρουαρίου, 2026

Nous-209 Efficiently Stimulates Immunity Against Neoantigens in Lynch Syndrome Carriers

Ogkologos - 3 Φεβρουαρίου, 2026

2026 ESMO TAT Honorary Award Recipient Announced

Ogkologos - 3 Φεβρουαρίου, 2026

2026 Heine H. Hansen Award Recipient Announced

Ogkologos - 3 Φεβρουαρίου, 2026

Longer RFS with Nivolumab Than with Ipilimumab Among Patients with Resected...

Ogkologos - 2 Φεβρουαρίου, 2026

Sacituzumab Govitecan Plus Pembrolizumab Prolongs PFS Among Patients with Previously Untreated,...

Ogkologos - 30 Ιανουαρίου, 2026

1...262728...432 Σελίδα 27 από 432

MOST POPULAR

Cemiplimab Prolongs Overall Survival Among Patients with Recurrent Cervical Cancer After...

16 Φεβρουαρίου, 2022

Fragment Analysis Is a More Reliable MET Exon 14 Screening Strategy...

9 Οκτωβρίου, 2020

Coverage for Breast Cancer Genetic Marker Testing is Still Being Denied...

20 Ιουλίου, 2021

4 Ways to Avoid Comparing Yourself to Others on Social Media...

31 Οκτωβρίου, 2023

Φόρτωση περισσοτέρων

PAXG Significantly Improves EFS Compared with mFOLFIRINOX in Patients with Resectable...

EMA Recommends Extension of Therapeutic Indications for Retifanlimab

Adding Palbociclib to Maintenance Anti-HER2 and Endocrine Therapies Improves PFS Over...

FDA Grants Traditional Approval to Pirtobrutinib for Chronic Lymphocytic Leukaemia and...

ESMO Launches Its Roadmap 2030 to Support Oncology Professionals and Foster...

Nous-209 Efficiently Stimulates Immunity Against Neoantigens in Lynch Syndrome Carriers

2026 ESMO TAT Honorary Award Recipient Announced

2026 Heine H. Hansen Award Recipient Announced

Longer RFS with Nivolumab Than with Ipilimumab Among Patients with Resected...

Sacituzumab Govitecan Plus Pembrolizumab Prolongs PFS Among Patients with Previously Untreated,...

MOST POPULAR

Cemiplimab Prolongs Overall Survival Among Patients with Recurrent Cervical Cancer After...

Fragment Analysis Is a More Reliable MET Exon 14 Screening Strategy...

Coverage for Breast Cancer Genetic Marker Testing is Still Being Denied...

4 Ways to Avoid Comparing Yourself to Others on Social Media...

HOT NEWS

EMA Recommends Extension of Therapeutic Indications for Cabozantinib

Spotlight On: Occupational Therapists in Cancer Care

Risk of Anal Cancer Significantly Lower with Treatment for Anal High-Grade...

Cancer in My Community: Reducing Tobacco Use in Tunisia

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ